These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3490203)

  • 21. High dose methotrexate infusion with leucovorin rescue for treatment of ectopic pregnancy.
    Larson DM; Tipping SJ; Mulligan GM; Johnson KK; Becker J
    Wis Med J; 1995 Dec; 94(12):664-7. PubMed ID: 8571615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetic analysis of high-dose methotrexate treatments in children with hematologic malignancies].
    Csordás K; Eipel O; Hegyi M; Csóka M; Pap E; Kovács G
    Orv Hetil; 2011 Oct; 152(40):1609-17. PubMed ID: 21945870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversed-phase high-performance liquid chromatographic analysis of methotrexate and 7-hydroxymethotrexate in serum.
    Cohen JL; Hisayasu GH; Barrientos AR; Nayar MS; Chan KK
    J Chromatogr; 1980 Mar; 181(3-4):478-83. PubMed ID: 7391163
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
    Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB
    Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of methotrexate in man after high and conventional doses.
    Chan KK; Nayar MS; Cohen JL; Chlebowski RT; Liebman H; Stolinsky D; Mitchell MS; Farquhar D
    Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):551-61. PubMed ID: 7403667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
    Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
    Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in glomerular filtration rate associated with high-dose methotrexate therapy in adults.
    Howell SB; Carmody J
    Cancer Treat Rep; 1977 Oct; 61(7):1389-91. PubMed ID: 303938
    [No Abstract]   [Full Text] [Related]  

  • 28. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
    Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
    J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dichloromethotrexate--a critical reassessment.
    O'Dwyer PJ; Leyland-Jones B; Alonso MT; Eisenberger M; Hoth DF
    J Clin Oncol; 1985 Aug; 3(8):1148-53. PubMed ID: 4020413
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental study on pharmacokinetics of methotrexate and its metabolite (7-hydroxy-methotrexate) in tissue].
    Sasaki K; Hosoya R; Wang YM; Sutow WW; Fujimoto T
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1678-87. PubMed ID: 7184366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of methotrexate diglutamate in human liver during methotrexate therapy.
    Jacobs SA; Derr CJ; Johns DG
    Biochem Pharmacol; 1977 Dec; 26(23):2310-3. PubMed ID: 588313
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relation of pharmacokinetics and toxicity of methotrexate at high dose].
    Mini E; Mazzei T; Ciuffi M; Ruggeri M; Benini A; Carniani E
    G Ital Chemioter; 1979; 26(1-2):387-96. PubMed ID: 318004
    [No Abstract]   [Full Text] [Related]  

  • 33. [High-dose methotrexate with citrovorum factor rescue in the treatment of malignant tumors (author's transl)].
    Wang QL; Sun Y; Zhou JC; Song SZ; Lu L; Ye ZS
    Zhonghua Zhong Liu Za Zhi; 1979; 1(2):144-9. PubMed ID: 317948
    [No Abstract]   [Full Text] [Related]  

  • 34. Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion.
    Chabner BA; Stoller RG; Hande K; Jacobs S; Young RC
    Drug Metab Rev; 1978; 8(1):107-17. PubMed ID: 363377
    [No Abstract]   [Full Text] [Related]  

  • 35. [Leucovorin rescue after continuing infusion of high dose methotrexate].
    Yang LH; Lu XT; Gu J; Hua Y; Zhao WH
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):393-4. PubMed ID: 15924763
    [No Abstract]   [Full Text] [Related]  

  • 36. A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue.
    Stoller RG; Kaplan HG; Cummings FJ; Calabresi P
    Cancer Res; 1979 Mar; 39(3):908-12. PubMed ID: 311683
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase I trial of high-dose methotrexate with modified citrovorum factor rescue.
    Jacobs SA; Santicky MJ
    Cancer Treat Rep; 1978 Mar; 62(3):397-9. PubMed ID: 348306
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of methotrexate in human plasma by high-pressure liquid chromatography with fluorescence detection.
    Nelson JA; Harris BA; Decker WJ; Farquhar D
    Cancer Res; 1977 Nov; 37(11):3970-3. PubMed ID: 302738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
    Chládková J; Hak J; Martínková J; Chládek J
    Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
    Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
    Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.